Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations.
FDA approves new therapy for glioma patients for first time in decades retrieved 7 August 2024 from https://medicalxpress.com/news/2024-08-fda-therapy-glioma-patients-decades.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves vorasidenib for Grade 2 gliomas with IDH mutationsVorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations.
Read more »
FDA-approved iron-chelating drug could provide a novel way to attack ovarian tumorsAn iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Read more »
Mexican drug lord El Chapo's son and his former partner arrested for 'leading drug cartel'Joaquin Guzman Lopez, the son of the notorious drug lord, and Ismael 'El Mayo' Zambada, who co-founded the Sinaloa Cartel with El Chapo, were arrested in Texas, the US Justice Department said.
Read more »
Moms and caregivers facing family food insecurity need help with more than just food, researchers sayPeople don't experience food insecurity the same way. Often, it's the mothers who first change their eating habits when food runs low to shield others, especially children, from its effects.
Read more »
And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testingA team of researchers from Henan University of Science and Technology have introduced a novel method for improving drug testing for esophageal cancer (EC) using advanced three-dimensional (3D) cell culture technology.
Read more »
Diabetes drug reduces drug resistance in lung cancer, improving chemotherapy effectivenessA medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine published in Clinical Cancer Research.
Read more »